LALiza Ashbrook

Liza Ashbrook

*This is an algorithmically generated author record based on publicly available information.

Liza Ashbrook has a total of 157 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chapter 9: Sleep Medicine

    by Nathaniel H. Fleming, Liza Ashbrook

  • Top Cited Papers

    International Consensus Statement on Obstructive Sleep Apnea

    by Jolie L. Chang, Andrew N. Goldberg, Jeremiah A. Alt, Alzoubaidi Mohammed, Liza Ashbrook, Dennis Auckley, Indu Ayappa, Hira Bakhtiar, José E. Barrera, Bethany L. Bartley, et al.

    Background: Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA).Methods: Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence‐based review (EBR), or evidence‐based review with recommendations (EBR‐R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus.Results: The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic testing types, multiple treatment modalities, and effects of OSA treatment on multiple OSA‐associated comorbidities. Specific focus on outcomes with positive airway pressure (PAP) and surgical treatments were evaluated.Conclusion: This review of the literature consolidates the available knowledge and identifies the limitations of the current evidence on OSA. This effort aims to create a resource for OSA evidence‐based practice and identify future research needs. Knowledge gaps and research opportunities include improving the metrics of OSA disease, determining the optimal OSA screening paradigms, developing strategies for PAP adherence and longitudinal care, enhancing selection of PAP alternatives and surgery, understanding health risk outcomes, and translating evidence into individualized approaches to therapy.


  • Advanced sleep phase type

    by Liza H. Ashbrook, Louis J. Ptáček


  • Open Access

    0172 Behavioral Drive in Familial Natural Short Sleepers and Their Unaffected Family Members

    by Liza Ashbrook, Andrew Krystal, Ying-Hui Fu, Louis Ptacek

    Those with familial natural short sleep (FNSS) report short sleep duration since youth. Mutations in four different genes in five families have been described leading to this autosomal dominant sleep pattern. Individuals with FNSS also have a cluster of other traits in addition to short sleep than can be termed “behavioral drive.” Here we describe a new behavioral drive scale that aims to capture the distinct phenotype of those with FNSS. Individuals reporting fewer than 6.5 hours of sleep when allowed to sleep ad libitum without any sleep-related complaint were interviewed to determine FNSS affected status from 2009 to 2021. Seven distinct non-sleep related traits were selected by consensus within the study team based on interviews with participants. Participants provided a self-rating on their degree of energy, pain tolerance, physical activity, ability to handle stress, productivity, hours working, and mental activity compared to other of the same age. Symptoms of mania and ADHD were also rated. 77 individuals meeting criteria for FNSS were enrolled along with 27 unaffected family members. Compared to unaffected family members, those with FNSS reported significantly more energy, pain tolerance, physical activity, ability to sit still, hours working, and mental activity. There was a trend towards significance for productivity. Four features of bipolar disorder were also queried, reckless decisions, rapid speech, impulsivity, and irritability, and there was no significant difference for any of these items between groups. Two symptoms of ADHD were included, concentration trouble and ability to sit still. Those with FNSS reported less concentration trouble than peers and an equal ability to sit still. Those with FNSS have multiple distinct traits including greater energy, pain tolerance, physical activity, ability to handle stress, hours working, and mental activity compared to unaffected family. When grouped together these traits can be titled “behavioral drive.” Further work will aim for validation of this scale in gene carriers and larger populations. This work was supported by NIH grants NS099333, NS072360 and NS104782 to L.J.P. and Y-H.F., and by the William Bowes Neurogenetics Fund to L.J.P. and Y.H.F.

  • Processed electroencephalography: impact of patient age and surgical position on intraoperative processed electroencephalogram monitoring of burst-suppression

    by D. Pleasants, R. Zak, L. H. Ashbrook, L. Zhang, C. Tang, D. Tran, M. Wang, S. Tabatabai, J. M. Leung

    We previously reported that processed EEG underestimated the amount of burst suppression compared to off-line visual analysis. We performed a follow-up study to evaluate the reasons for the discordance. Forty-five patients were monitored intraoperatively with processed EEG. A computer algorithm was used to convert the SedLine® (machine)-generated burst suppression ratio into a raw duration of burst suppression. The reference standard was a precise off-line measurement by two neurologists. We measured other potential variables that may affect machine accuracy such as age, surgery position, and EEG artifacts. Overall, the median duration of bust suppression for all study subjects was 15.4 min (Inter-quartile Range [IQR] = 1.0–20.1) for the machine vs. 16.1 min (IQR = 0.3–19.7) for the neurologists’ assessment; the 95% limits of agreement fall within − 4.86 to 5.04 s for individual 30-s epochs. EEG artifacts did not affect the concordance between the two methods. For patients in prone surgical position, the machine estimates had significantly lower overall sensitivity (0.86 vs. 0.97; p = 0.038) and significantly wider limits of agreement ([− 4.24, 3.82] seconds vs. [− 1.36, 1.13] seconds, p = 0.001) than patients in supine position. Machine readings for younger patients (age < 65 years) had higher sensitivity (0.96 vs 0.92; p = 0.021) and specificity (0.99 vs 0.88; p = 0.007) for older patients. The duration of burst suppression estimated by the machine generally had good agreement compared with neurologists’ estimation using a more precise off-line measurement. Factors that affected the concordance included patient age and position during surgery, but not EEG artifacts.


  • Open Access

    Extreme morning chronotypes are often familial and not exceedingly rare: the estimated prevalence of advanced sleep phase, familial advanced sleep phase, and advanced sleep–wake phase disorder in a sleep clinic population

    by Brian John Curtis, Liza H Ashbrook, Terry Young, Laurel A Finn, Ying-Hui Fu, Louis J Ptáček, Christopher R Jones

    Study Objectives: Report the first prevalence estimates of advanced sleep phase (ASP), familial advanced sleep phase (FASP), and advanced sleep–wake phase disorder (ASWPD). This can guide clinicians on the utility of screening for extreme chronotypes both for clinical decision-making and to flag prospective participants in the study of the genetics and biology of FASP.Methods: Data on morning or evening sleep schedule preference (chronotype) were collected from 2422 new patients presenting to a North American sleep center over 9.8 years. FASP was determined using a severity criterion that has previously identified dominant circadian mutations in humans. All patients were personally seen and evaluated by one of the authors (C.R.J.).Results: Our results demonstrate an ASP prevalence of 0.33%, an FASP prevalence of 0.21%, and an ASWPD prevalence of at least 0.04%. Most cases of young-onset ASP were familial.Conclusions: Among patients presenting to a sleep clinic, conservatively 1 out of every 300 patients will have ASP, 1 out of every 475 will have FASP, and 1 out of every 2500 will have ASWPD. This supports obtaining a routine circadian history and, for those with extreme chronotypes, obtaining a family history of circadian preference. This can optimize treatment for evening sleepiness and early morning awakening and lead to additional circadian gene discovery. We hope these findings will lead to improved treatment options for a wide range of sleep and medical disorders in the future.